Socioeconomic status and central adiposity as determinants of stress-related biological responses relevant to cardiovascular disease risk by Andrew Steptoe (36331) et al.
Contents lists available at ScienceDirect
Brain, Behavior, and Immunity
journal homepage: www.elsevier.com/locate/ybrbi
Full-length Article
Socioeconomic status and central adiposity as determinants of stress-related
biological responses relevant to cardiovascular disease risk
Andrew Steptoea,⁎, Tanja-Julia Hiltla, Jennifer Beam Dowdb, Mark Hamera,c
a Department of Behavioural Science and Health, University College London, London WC1E 6BT, UK
bDepartment of Global Health and Social Medicine, King’s College London, London WC2R 2LS, UK
c School of Sport, Exercise and Health Sciences, Loughborough University, Leicestershire LE11 3TU, UK
A R T I C L E I N F O
Keywords:
Stress reactivity
Interleukin 6
Obesity
Cytomegalovirus
Cortisol
Blood pressure
A B S T R A C T
Stress-related processes have been implicated in the associations between lower socioeconomic status (SES),
central adiposity, and cardiovascular disease risk. This study analysed the impact of SES and central adiposity on
cardiovascular, inflammatory and neuroendocrine stress responses, and associations with cytomegalovirus
(CMV) infection in a sample of 537 men and women aged 53–76 years (mean 62.89 years). SES was defined by
grade of employment (higher, intermediate, and lower categories), and central adiposity was indexed by waist-
hip ratio (WHR). Cardiovascular, inflammatory and cortisol responses were monitored during administration of
a standardized mental stress testing protocol and salivary cortisol was measured repeatedly over the day. Lower
SES was associated with raised systolic and diastolic blood pressure (BP), plasma interleukin (IL-6), fibrinogen,
C-reactive protein, and salivary cortisol, and a large WHR accentuated SES differences in fibrinogen, C-reactive
protein, and likelihood of CMV seropositivity, independently of general adiposity indexed by body mass index.
During mental stress testing, return to resting levels (recovery) following behavioural challenge in systolic and
diastolic BP and heart rate was impaired among lower SES participants, particularly those with large WHR.
Lower SES participants had greater cortisol concentrations across the day, but this pattern did not vary with
WHR. These findings extend the evidence relating lower SES to stress-related biological risk factors for cardi-
ovascular disease, and indicate that central adiposity may augment these effects.
1. Introduction
There are marked socioeconomic disparities in cardiovascular dis-
ease (CVD), with greater incidence of coronary heart disease (CHD),
hypertension and stroke in lower socioeconomic status (SES) groups
defined by occupation, education, income or self-defined social status
(Kerr et al., 2011; Leng et al., 2015; Manrique-Garcia et al., 2011; Tang
et al., 2016). Lifestyle factors such as smoking and sedentary behaviour
make an important contribution to SES differences (Stringhini et al.,
2011), but direct influences on biological processes implicated in CVD
are also relevant (Kivimaki and Steptoe, 2018). Psychological stress
elicits disturbances in autonomic regulation, neuroendocrine factors,
inflammatory markers and endothelial function (Boylan et al., 2018;
Marsland et al., 2017; Wirtz and von Kanel, 2017). Studies of acute
mental stress have shown that lower SES is associated with delayed
recovery (return towards baseline after stress) in systolic and diastolic
blood pressure (BP) and in haemostatic variables, together with ele-
vated concentration of markers of inflammation such as interleukin 6
(IL-6) (Boylan et al., 2018; Brydon et al., 2004). These responses are
markers of chronic allostatic load (McEwen and Gianaros, 2010), and
predict future cardiovascular morbidity (Panaite et al., 2015; Steptoe
et al., 2016).
Central or visceral adiposity is a growing health problem, and is a
pivotal risk factor for cardiometabolic disease (Balkau et al., 2007;
Despres, 2012). Fat deposits in the abdominal visceral region are highly
active in terms of autonomic, immune and neuroendocrine regulation,
with inflammation, sympathetic nervous system activation, and dis-
turbances of hypothalamic-pituitary-adrenocortical (HPA) function
being implicated in central adiposity (Bjorntorp, 2001; Mancia et al.,
2007; Speaker and Fleshner, 2012). Psychological stress may contribute
to the development of central adiposity through alterations in stress
biology (Dallman et al., 2005; Tomiyama, 2018). A positive association
between central adiposity, inflammatory cytokine responses, and de-
layed BP recovery following acute mental stress has been described
(Brydon et al., 2008; McInnis et al., 2014; Steptoe and Wardle, 2005),
although an inverse association with heart rate and cortisol responses to
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stress has also been noted (Jones et al., 2012; Phillips et al., 2012).
Since central adiposity is more common among lower than higher
SES groups, it is possible that the two share common pathways to
cardiovascular risk through disturbed stress biology. However, the
combined effect of lower SES and central adiposity has not previously
been examined. We therefore investigated the impact of SES and central
adiposity on inflammatory, hemodynamic and neuroendocrine re-
sponses to psychological stress in a sample of healthy middle-aged and
older men and women drawn from the Whitehall II epidemiologic co-
hort. We hypothesized that lower SES and greater central adiposity
would be associated with delayed cardiovascular (BP and heart rate)
recovery following acute stress, with greater inflammatory responses to
stress, greater cortisol output over the day, and with higher baseline
levels. We further conjectured that these two factors might be sy-
nergistic, with the greatest responses emerging among lower SES in-
dividuals with greater central adiposity. Because the focus of this study
was on central adiposity, body mass index (BMI) was included as a
covariate in the analyses to take account of overall adiposity.
We also evaluated associations between SES and central adiposity
and cytomegalovirus (CMV) serostatus. Herpesviruses such as CMV are
frequently acquired early in life, and are more common among lower
SES individuals as defined by education, poverty or parental occupa-
tional status (Dowd et al., 2012; Janicki-Deverts et al., 2014; Simanek
et al., 2009). Positive CMV serostatus has been shown to predict future
cardiovascular disease (Hui et al., 2016; Ji et al., 2012), and is im-
plicated in inflammatory diseases and in the dysregulation of the hy-
pothalamic-pituitary-adrenocortical (HPA) axis as well. We have pre-
viously found that CMV is associated with a flatter cortisol rhythm over
the day, and with accelerated telomere shortening over three years
(Dowd et al., 2017; Steptoe et al., 2009). CMV also affects metabolic
processes, though associations with adiposity are poorly understood
(Fleck-Derderian et al., 2017). Associations between CMV ser-
opositivity, SES and central adiposity were therefore assessed in this
study.
2. Methods
2.1. Participants
We recruited a sample of 543 healthy white European men
(n=294) and women (n=249) aged 53–76 years
(M=62.89 ± 5.65) from the Whitehall II epidemiological cohort of
British civil servants (Marmot et al., 1991). To be included in the study
the participants were required to have no history of CHD, hypertension,
inflammatory conditions or allergies. These criteria were used because
the overarching aim of the study was to investigate psychosocial and
biological risk factors for CHD (Hackett et al., 2012; Steptoe et al.,
2010). Since one of the primary purposes of the study was to compare
SES groups, we used a stratified sampling method to recruit potential
participants from higher, intermediate, and lower grade of employment
categories in the Whitehall II cohort. Because of the differences in
cardiovascular disease across the socioeconomic gradient, there were
fewer lower than higher or intermediate grade disease-free individuals
eligible for the study, so the lower grade group was smaller. Partici-
pants were instructed not to take any anti-inflammatory or anti-hista-
mine medication in the seven days prior to the testing day and to refrain
from drinking alcohol and excessive exercise from the previous evening.
The participants were also required to avoid caffeinated beverages and
smoking at least 2 h prior to the testing session. Individuals presenting
with colds or infections on the testing day were rescheduled. Civil
service employment grade was used to divide participants into low,
intermediate and high SES groups. Waist-hip ratio (WHR) was used to
divide participants into low and high central adiposity groups with sex-
specific median cut points (men 0.943, women 0.801). Six participants
were excluded from the analysis because of incomplete data. All par-
ticipants gave full informed consent and the study was approved by the
University College London Hospitals Committee on the Ethics of Human
Research.
2.2. Procedures
Questionnaires were completed before the mental stress testing
sessions that were conducted individually in a light and temperature
controlled laboratory in either the morning or the afternoon between
2006 and 2008. At the start of the session, anthropometric measure-
ments were taken. Height was measured to the nearest 0.1 cm using a
stadiometer and weight was measured in kilos (kg) using Tanita Scales.
Body Mass Index (BMI) was subsequently calculated using this in-
formation (kg/m2). Waist circumference was assessed using a metal
tape halfway between the bottom rib and iliac crest, and hip cir-
cumference was measured at the level of the great trochanters. The
measurements were conducted twice to ensure accuracy, and WHR was
calculated as waist circumference/hip circumference.
Following these measurements, the participant was seated and a
venous cannula was inserted into the lower arm for the collection of
blood samples. Systolic BP, diastolic BP and heart rate were assessed
continuously using a Finometer (Finapres Medical Systems,
Amsterdam). There followed a 30min resting period, the last 5 min of
which was used to measure baseline systolic and diastolic BP and heart
rate. At this time the first blood sample was drawn into EDTA and ci-
trated tubes, and a saliva sample was taken using Salivettes (Sarstedt,
Leicester, UK).
Two 5-minute behavioural tasks that have been used to induce
stress in a number of previous studies were then administered in a
counterbalanced order (Steptoe et al., 2002b). These tasks have been
shown to elicit consistent cardiovascular and inflammatory responses
on repeat testing (Hamer et al., 2006). The first was a computerized
version of the Stroop colour-word-interference task. Participants had to
press a computer key to choose one out of four words that matched the
colour of the target word presented at the centre of the screen. Target
and distractor words were printed in incongruous colours (e.g. the word
blue printed in red, etc.). The second task was mirror tracing, involving
the tracing of a star with a metal stylus which could only be seen in
mirror image. The device emitted a loud beep with every error. Parti-
cipants were told that people usually manage to finish five circuits of
the star during the allocated time.
A second blood sample and a saliva sample were taken immediately
after the tasks, while systolic and diastolic BP and heart rate were
measured continuously throughout the tasks and recovery period.
Further blood samples were obtained 45min and 75min after task
completion, with saliva samples at 20, 45 and 75min during the re-
covery period.
Following the mental stress testing session, participants were asked
to take 5 saliva samples over the next day, following methods pre-
viously used in this laboratory (Kunz-Ebrecht et al., 2004). Samples
were requested on waking, 30min later, at 10:00 h, 16:00 h and
20:00 h, and were sent back to the research office and stored at−20 °C.
2.3. Blood and salivary measures
Blood samples were centrifuged immediately at 2500 rpm for
10min at room temperature and the separated plasma was aliquoted
into 0.5 ml portions stored at −80 °C until further analysis. Three in-
flammatory markers were analysed. Plasma IL-6 was assayed using a
Quantikine high sensitivity two-site enzyme-linked immunosorbent
assay (ELISA) from R&D Systems (Oxford, UK). The sensitivity of the
assay ranged from 0.016 to 0.110 pg/ml and the intra and inter assay
CVs were 7.3% and 7.7% respectively. Fibrinogen was measured from
citrated blood with an automated Clauss assay in a MDA-180 coagul-
ometer (Oragon Teknika, Cambridge, UK) using the manufacturer's
reagents and the International Fibrinogen Standard, with inter- and
intra-individual CVs of 8%. High sensitivity C-reactive protein was
A. Steptoe et al. Brain, Behavior, and Immunity 77 (2019) 16–24
17
assayed in duplicate with a high sensitivity enzyme immunoassay kit
(BioCheck, CA, USA). Glycated haemoglobin (HbA1c) was measured
using a Tosoh G7 high performance liquid chromatography analyser
(San Francisco, CA) calibrated to Diabetes Control and Complications
Trial standards. CMV IgG antibody titres were measured from thawed
serum samples using a solid-phase enzyme immunoassay system as
described previously (Dowd et al., 2013). A sample was categorized as
seropositive if the optical density ratio was 1.0 or greater as read by a
spectrophotometer. All CMV assays were carried out by the Stanley
Neurovirology Laboratory of the Johns Hopkins University School of
Medicine. Saliva samples were stored at −20 °C until analysis at the
University of Dresden. Cortisol levels were assessed from saliva using a
time resolved immunoassay with fluorescence detection, and the intra-
and inter-assay coefficients of variation (CVs) were less than 8%.
2.4. Statistical analyses
Sociodemographic factors were compared across SES and WHR
groups using analysis of variance for continuous and Chi2 tests for ca-
tegorical variables. Cardiovascular data were averaged over 4 periods:
the last 5 min of the baseline period (baseline), the two behavioural task
trials, and 40–45min and 70–75min following tasks (recovery phase).
Heart rate variability was modelled as root mean square of successive
differences (RMSSD) over the same time periods, and was log trans-
formed before analysis because of negative skew. The total cortisol
output over the stress session was computed using the area under the
curve (AUC) method (Pruessner et al., 2003), and a similar method was
used to quantify cortisol output over the day. Cortisol over the day was
negatively skewed so log transformed before analysis, but raw values
are shown in Section 3. There were 41 women with current or recent
hormone replacement treatment, but including this factor into account
did not modify the results, so it was not included in the final models.
Baseline values of biomarkers were analysed by analysis of covar-
iance with SES (grade of employment) and central adiposity (WHR)
group as between-person factors, covarying for age, sex, and smoking
status, since these potentially influence results. Analyses of salivary
cortisol also included time of day of laboratory session (morning/
afternoon) as a covariate. In order to identify effects related specifically
to central adiposity, BMI was added as a further covariate to all ana-
lyses. Linear contrasts tested gradients across SES groups. The number
of participants included in each analysis differed because of missing
data, so the sample sizes are indicated in Section 3.
Stress responses were analysed using repeated measures analysis of
variance with SES and WHR as between-person factors and trial as the
within-person factor. There were 4 trials in the cardiovascular and IL-6
analyses: baseline, during task for cardiovascular variables and im-
mediately after tasks for IL-6, and 45 and 75min after tasks. Fibrinogen
was sampled at 3 time points since levels return to baseline promptly
after stress: baseline, immediately after tasks, and at 45min (Steptoe
et al., 2003b). Salivary cortisol was analysed across 5 trials (baseline,
immediately after tasks, and 20, 45 and 75min after tasks), and also by
analysing the AUC for the session. The Greenhouse–Geisser correction
of degrees of freedom was applied where appropriate. Stress reactivity
was further analysed with difference scores between baseline and stress
tasks, while post-stress recovery in cardiovascular variables was as-
sessed as differences between task and recovery trials, with higher va-
lues indicating greater recovery.
C-reactive protein and HbA1c were measured once, and were ana-
lysed in the same fashion as the baseline values of biomarkers. We
analysed CMV serostatus using logistic regression, and present the odds
of CMV positivity (with 95% confidence intervals, CI) adjusted for age,
sex, smoking status and BMI, with the higher SES / small WHR group as
the reference category.
We also carried out two sensitivity analyses. First, we investigated
the impact of WHR modelled as a continuously distributed as opposed
to a categorical variable. Because of sex differences in WHR, normalised
scores were used in these analyses. Second, we reanalysed all data with
only SES and WHR in the models, without covarying for age, sex,
smoking status, and BMI.
3. Results
There were 207 higher, 209 intermediate and 121 lower SES par-
ticipants as defined by occupational grade (Table 1). There was a sig-
nificant difference in age across SES groups (F(2,531)= 4.23,
p=0.015, since the lower SES participants were slightly older on
average. Lower SES participants were more likely to be unmarried
(p=0.007), while educational attainment was positively associated
with SES, with a substantially greater number of higher than lower SES
volunteers being educated to University level (p < 0.001). There was
no difference in the proportion of participants in the small and large
WHR categories across SES groups, and no difference in gender dis-
tribution. As might be expected, BMI, average waist circumference and
average hip circumference were all greater in the large than small WHR
groups (p < 0.001). Additionally, there was a non-linear SES differ-
ence in waist circumference (p=0.007), with slightly larger waists on
average in intermediate than higher or lower SES respondents. There
was a moderate positive correlation between WHR and BMI (r=0.41),
but tests for multicollinearity (variance inflation factors and tolerance)
were all within acceptable ranges. Measures of task appraisal showed
no differences related to SES or WHR in the extent to which tasks were
perceived as difficult, involving, or controllable (results not shown).
3.1. Resting differences in biological activity
Baseline levels of cardiovascular, inflammatory and other biological
Table 1
Characteristics of the study sample.
Socioeconomic status
Higher (N=207) Intermediate (N=209) Lower (N=121)
Waist-hip ratio grouping Small Large Small Large Small Large
N 107 100 109 100 52 69
Age (years) 62.70 (5.78) 61.81 (5.26) 62.57 (5.49) 62.94 (5.56) 63.31 (5.71) 64.94 (6.11)
Sex (% men) 55 (51.4%) 59 (59.0%) 65 (59.6%) 58 (47.2%) 23 (44.2%) 28 (40.6%)
Marital status: unmarried (%) 38 (35.5%) 29 (29.3%) 35 (32.1%) 32 (32.0) 22 (42.3%) 35 (50.7%)
Education to University degree level (%) 61 (57.5%) 68 (68.7%) 30 (28.0%) 18 (18.8%) 4 (8.5%) 5 (8.2%)
Current smokers (%) 4 (3.7%) 6 (6.0%) 2 (1.8%) 10 (10.0%) 5 (9.6%) 3 (4.3%)
BMI (kg/m2) 23.97 (2.84) 27.55 (4.36) 24.72 (3.66) 27.32 (3.65) 23.94 (3.41) 27.51 (3.46)
Waist circumference (cm) 78.26 (9.35) 95.29 (11.03) 81.46 (10.93) 94.70 (10.68) 77.15 (9.41) 91.50 (9.93)
Hip circumference (cm) 95.6 (6.24) 101.2 (9.41) 97.7 (7.29) 100.2 (7.86) 95.1 (7.57) 100.6 (8.25)
Values are presented as Means (SD) and N (%).
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measures are summarized in Table 2, adjusted for age, sex, smoking
status and BMI. There were significant SES gradients in systolic and
diastolic BP (F(2,512)= 10.28 and 7.47, p < 0.001), with lower BP in
higher status participants. There were no SES differences in heart rate
or heart rate variability at baseline. Systolic BP was not related to WHR,
but both diastolic BP and heart rate were higher in the large WHR
category after adjusting for covariates (F(1,512)= 5.83, p=0.016 and
F (1,469)= 4.40, p=0.037). Baseline plasma IL-6 (F(2,509)= 3.03),
fibrinogen (F(2,506)= 4.83) and C-reactive protein (F(2,510)= 2.29)
all showed significant gradients across SES groups (all p=0.033 or
greater), with higher levels of inflammation in lower SES groups after
adjustment for covariates. There was an SES gradient in baseline sali-
vary cortisol as well (F(2,512)= 3.67, p=0.009), with a higher con-
centration in lower SES participants. There were no significant differ-
ences in HbA1c levels. The interaction between SES and WHR was
significant for plasma fibrinogen, (F(2,506)= 9.46, p < 0.001), and C-
reactive protein, (F(2,510)= 4.20, p=0.016). In both cases, the
highest values were observed in the lower SES/large WHR group.
3.2. Cardiovascular responses to acute stress
Repeated measures analysis of variance of systolic BP identified a
main effect of SES (F(2,508)= 8.17, p < 0.001), together with an SES
by trial interaction (F(6,1524)= 3.58, p=0.005), and a 3-way SES by
WHR by trial cubic effect (F(6,1524)= 3.24, p=0.040). In the case of
diastolic BP, there were main effects of WHR (F(2,507)= 5.73,
p=0.017) and SES (F(2,507)= 7.21, p < 0.001), plus significant SES
by trial (F(6,1521)= 4.50, p < 0.001), and SES by WHR by trial cubic
effects (F(2,507)= 3.36, p=0.036). These results are summarised in
Fig. 1, where it is apparent that BP increased markedly in response to
mental stress, returning towards baseline during the recovery period.
There was no difference in systolic BP reactions to tasks in relation to
SES or WHR, but differences emerged during the recovery period. After
adjustment for age, sex, smoking status and BMI, there was a significant
SES gradient in the extent of recovery at 45min (F(2,508)= 5.12,
p < 0.001) and 75min following stress (F(2,508)= 12.70,
p < 0.001). SES effects remained significant after additional control
for baseline and levels during tasks (F(2,505)= 3.57 and 3.93,
p=0.008 and 0.011 respectively), so were not secondary to any dif-
ferences in baseline or stress reactivity. Additionally, SES and WHR
interacted in recovery at 45min (F(2,508)= 4.01, p=0.019). These
results are summarized in Table 3, and show that the amount of im-
paired recovery in the lower SES group was accentuated in the large
WHR category. A similar pattern emerged for diastolic BP, with SES
differences at 45 and 75min (F(2,507)= 6.01 and 7.07, p=0.003),
with a SES and WHR interaction at 45min showing that central adip-
osity moderated these SES differences (F(2,507)= 4.03, p=0.018). As
in the case of systolic BP, SES differences in recovery remained
significant following additional adjustment for baseline and task levels
at 45 min (F(2,504)= 4.57, p=0.004) and 75min (F(2,504)= 6.94,
p=0.002).
The analysis of heart rate revealed an SES by trial interaction (F
(6,1380)= 4.02, p < 0.001) and a main effect of WHR (F(1,
460)= 4.34, p=0.034), but no 3-way interaction. In contrast with the
BP results, there was a significant difference in heart rate reactions
across SES groups (F(2,469)= 4.36, p=0.004), with larger increases
in the higher SES compared with lower SES participants (see Fig. 2).
However, SES differences in recovery were the same as for BP at 45min
and 75min (F(2,463)= 4.86 and 4.59, p=0.004), with more effective
recovery among higher SES participants (Table 3). These recovery ef-
fects remained significant with additional control for baseline levels.
Heart rate variability also changed in response to the stress protocol (F
(3,1314)= 231.5, p < 0.001), falling from baseline during tasks, and
Table 2
Baseline levels of biological measures.
Socioeconomic status
Higher (207) Intermediate (209) Lower (121)
Waist-hip ratio grouping Small Large Small Large Small Large
Systolic BP (mmHg) N=522 122.28 (13.95) 124.76 (14.29) 124.44 (14.82) 127.36 (14.41) 132.22 (15.22) 129.96 (14.57)
Diastolic BP (mmHg) N=520 71.53 (8.51) 74.17 (8.31) 73.41 (10.76) 75.54 (9.82) 76.13 (9.11) 78.08 (10.31)
Heart rate (bpm) N=479 65.85 (9.20) 67.13 (9.15) 65.81 (9.28) 67.19 (8.88) 65.08 (7.21) 68.28 (9.61)
Heart rate variability (rms, ln) N=446 3.05 (0.38) 3.09 (0.52) 3.08 (0.45) 3.04 (0.49) 3.07 (0.49) 3.02 (0.55)
Plasma IL-6 (pg/ml) N=519 1.19 (0.74) 1.28 (0.74) 1.43 (1.02) 1.30 (0.71) 1.32 (0.57) 1.58 (0.93)
Plasma fibrinogen (g/L) N=516 3.06 (0.52) 3.09 (0.53) 3.20 (0.64) 3.02 (0.61) 3.08 (0.53) 3.48 (0.71)
Plasma C-reactive protein (mg/L) N=520 1.30 (1.24) 1.70 (2.21) 1.81 (2.34) 1.51 (1.76) 1.47 (1.18) 2.58 (3.69)
Salivary cortisol (ln, nmol/ml) N=523 1.84 (0.46) 1.90 (0.46) 1.85 (0.50) 1.92 (0.44) 1.99 (0.47) 2.03 (0.42)
HbA1c (mmol/mol) N=530 36.1 (3.40) 35.5 (5.04) 36.4 (3.56) 35.9 (4.83) 37.2 (10.30) 36.7 (4.15)
Values are presented as means (SD) and are adjusted for age, sex, smoking status and BMI. Salivary cortisol additionally adjusted for time of day of stress testing.
Fig. 1. Mean levels of systolic and diastolic BP in relation to SES and WHR at
baseline, during tasks, and 40–45min and 70–75min after task completion.
Lower SES – black; Intermediate SES – blue; Higher SES – red; solid lines – large
WHR; dashed lines – small WHR. Values are adjusted for age, sex, smoking
status and BMI. Error bars are standard error of the mean (sem). (For inter-
pretation of the references to colour in this figure legend, the reader is referred
to the web version of this article.)
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recovering above baseline after tasks. This pattern did not vary with
SES, but there was a significant WHR by trial interaction (F
(3,1302)= 2.81, p=0.048). Responses to tasks were comparable, but
the large WHR group showed better post-stress recovery than the small
WHR group at 45min (p=0.037).
3.3. Inflammatory and neuroendocrine responses to acute stress
Plasma IL-6 increased following stress, showing a delayed response
with raised levels 45 and 75min after tasks (F(3,1491)= 125.5,
p < 0.001). There was also a significant SES effect (F(2,493)= 2.30,
p=0.033), with higher IL-6 concentrations in lower SES participants
after adjustment for age, sex, smoking status and BMI (Fig. 2). The
acute inflammatory responses to stress did not differ across SES groups,
but the highest absolute levels were recorded in lower SES participants
following stress. Additionally, the WHR group by trial interaction was
significant (F(1,493)= 4.74, p=0.030). The large WHR group showed
smaller increases in IL-6 concentration over the session after adjustment
for covariates, but there was no interaction between SES and WHR. The
pattern of plasma fibrinogen responses differed from that for IL-6, in
that increases with tasks were immediate and transient (F
(2,992)= 4.99, p=0.007). There was a significant main effect for SES,
together with an SES by WHR interaction (F(2,496)= 8.29,
p < 0.001). As can be seen in Fig. 3, this was primarily attributable to
the substantially higher concentrations of fibrinogen in the lower SES/
large WHR group.
The salivary cortisol AUC showed a main significant effect of SES (F
(2,512)= 2.10, p=0.041, mirroring the socioeconomic gradient at
baseline described in Table 2. Additionally, analysis of individual
samples identified an SES by trial interaction illustrated in Fig. 3 (F
(2,512)= 4.13, p=0.017). The elevated cortisol in the lower SES
group is apparent throughout the session, but there is no clear re-
lationship with stress responsivity or recovery.
Table 3
Cardiovascular recovery following stress.
Socioeconomic status
Higher (207) Intermediate (209) Lower (121)
Waist-hip ratio grouping Small Large Small Large Small Large
Systolic BP (mmHg)
Recovery at 45min 26.60 (16.72) 22.46 (15.47) 19.45 (14.76) 22.38 (15.88) 22.15 (15.57) 16.22 (15.25)
Recovery at 75min 24.51 (16.36) 21.94 (16.98) 18.98 (14.85) 19.15 (16.79) 18.12 (13.86) 14.09 (13.26)
Diastolic BP (mmHg)
Recovery at 45min 11.38 (7.14) 10.04 (7.12) 7.23 (7.55) 9.84 (8.78) 8.63 (6.39) 7.53 (7.03)
Recovery at 75min 9.86 (6.85) 9.75 (8.45) 5.66 (7.29) 8.49 (8.18) 7.61 (6.76) 6.86 (7.00)
Heart rate (bpm)
Recovery at 45min 11.69 (7.59) 11.94 (7.59) 10.17 (7.19) 10.78 (5.43) 9.58 (5.17) 8.87 (7.48)
Recovery at 75min 11.87 (7.65) 11.48 (7.92) 9.88 (7.17) 10.39 (5.50) 9.20 (6.17) 9.18 (7.19)
Values are presented as means (SD) and are adjusted for age, sex, smoking status and BMI.
Fig. 2. Mean levels of heart rate and plasma IL-6 during or immediately after
tasks, and 40–45min and 70–75min after task completion. Heart rate results
are for SES only, while IL-6 findings are plotted in relation to SES and WHR. For
other details, see legend to Fig. 1.
Fig. 3. Mean levels of plasma fibrinogen and cortisol at baseline, immediately
after tasks, and at 20min (cortisol), 45min and 75min after task completion.
Fibrinogen results are for SES and WHR, while cortisol is plotted in relation to
SES only. For other details, see legend to Fig. 1.
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3.4. CMV serostatus, SES and central adiposity
A substantial proportion of respondents were positive for CMV, in-
dicating that past infection was relatively common. Table 4 summarises
the results in relation to SES and WHR. Logistic regression revealed that
the odds of CMV seropositivity were increased more than twofold in the
lower SES/large WHR group compared with the higher SES/small WHR
group after adjustment for covariates (p=0.009). The prevalence of
positive CMV serostatus was 44.8% in the higher SES/small WHR group
compared with 66.0% in the lower SES/large WHR group.
3.5. Cortisol across the day
There was a typical salivary cortisol profile across the day, with
high values on waking and an increase in cortisol 30 min later, followed
by progressive decline into the evening. Significant differences by SES
were apparent (F(2,458)= 4.93, p=0.006), with greater cortisol
output among lower SES individuals (Fig. 4). There was, however, no
interaction between SES and time of day, and no SES difference in the
rise in cortisol between waking and 30min later, or in the slope of
cortisol decline across the day. Cortisol output over the day was not
related to WHR, and there were no significant interactions between SES
and WHR. Analyses of men and women separately showed no differ-
ences in these patterns of change over the day (results not shown).
3.6. Sensitivity analyses
The first sensitivity analysis investigated whether associations
would be different if WHR modelled as a continuous variable rather
than categorising individuals as having larger or smaller WHR. The
results, summarised in Appendix A, Table 1, indicate very few differ-
ences from the categorical analyses. Three interactions between SES
and WHR were no longer significant with continuous WHR, but there
were no differences from the main analysis in baseline or resting effects
for systolic or diastolic BP, heart rate, HRV, IL-6, salivary cortisol or
CMV serostatus, and no differences from the main analysis in reactivity
or recovery effects for any outcome apart from diastolic BP. The pattern
of results for salivary cortisol over the day was unchanged.
The second sensitivity analysis assessed the associations of SES and
WHR with biology in the absence of statistical adjustment for age, sex,
smoking status and BMI. The results are summarised in Appendix A,
Table 2. Significant associations between WHR and resting HRV and
plasma IL-6 emerged that were not present in the main analysis. In
relation to systolic BP, the interaction between WHR and trial was
significant (this was conditional on SES in the main analysis), and there
was a main effect of WHR on plasma IL-6, with higher IL-6 in the larger
than smaller WHR group throughout the session. By contrast, the pre-
viously observed WHR by trial interaction was no longer significant.
These effects primarily emerged because of the absence of BMI as a
covariate. Otherwise, there were no differences from the main analyses
in baseline levels, stress reactivity and recovery, or in cortisol output
over the day.
4. Discussion
This study investigated the separate and combined associations
between lower SES and central adiposity and a range of stress-related
biological processes. We hypothesised that lower SES and greater cen-
tral adiposity (waist-hip ratio) would be associated with impaired post-
stress recovery in cardiovascular parameters, with heightened in-
flammatory and neuroendocrine responses to stress, and with greater
cortisol output over the day. We also conjectured that the combination
of lower SES and greater central adiposity would be particularly toxic.
The results confirmed and extended previous studies of SES and car-
diovascular, inflammatory and neuroendocrine factors, and identified
important interactions between lower SES and central adiposity in re-
lation to inflammatory markers, CMV infection, and post-stress re-
covery of cardiovascular function.
Associations between SES and acute cardiovascular stress re-
sponsivity have been investigated in a number of studies. A meta-ana-
lysis in 2018 showed no consistent relationship between SES and BP or
heart rate reactivity, but differences emerged in post-stress recovery,
albeit in a sample of only 6 studies (Boylan et al., 2018). The present
results are consistent with these conclusions and with a previous study
from our laboratory (Steptoe et al., 2002a), in showing impaired sys-
tolic and diastolic BP and heart rates recovery following stress in lower
SES participants. Heart rate variability did not follow this pattern, but
was only measured using RMSSD, and frequency-based parameters may
have been more sensitive. The study population was purposively re-
cruited using a stratified sampling procedure to ensure adequate re-
presentation of people from different SES groups who were in good
cardiometabolic health, assuaging some of the heterogeneity in sam-
pling present in some other studies. Interestingly, we observed higher
heart rate reactivity to tasks in the higher SES group. A similar pattern
has been reported previously, and may relate to the performance of
cognitive tasks as opposed to other types of behavioural challenge (de
Rooij, 2013). We selected the tasks in this study after pilot work on a
number of alternatives, choosing those that were appraised similarly by
people across the SES spectrum (Steptoe and Marmot, 2002), and there
were no differences in task appraisal in the present study.
Table 4
CMV serostatus, SES and central adiposity.
Group Percent (95% CI) Adjusted odds ratio (95% CI) p
Higher SES/small WHR 44.8% (34.8–54.7) Reference (1)
Higher SES/large WHR 47.2% (36.9–57.4) 1.10 (0.61–2.00) 0.75
Intermediate SES/small WHR 48.2% (38.5–57.8) 1.15 (0.66–2.00) 0.62
Intermediate SES/large WHR 44.5% (34.5–54.5) 0.98 (0.54–1.78) 0.96
Lower SES/small WHR 48.1% (34.2–62.0) 1.14 (0.57–2.29) 0.71
Lower SES/large WHR 66.0% (53.8–78.3) 2.47 (1.35–4.89) 0.009
Adjusted for age, sex, smoking status and BMI. N=511.
SES= socioeconomic status; WHR=waist-hip ratio
Fig. 4. Mean salivary cortisol concentration across the day in relation to SES.
For other details, see legend to Fig. 1.
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Although central adiposity did not affect cardiovascular reactivity
or recovery directly, we observed interactions between SES and WHR in
the post-stress recovery profile of systolic and diastolic BP. Blood
pressure recovery was markedly impaired in the lower SES /large WHR
group. For example, the decrease in systolic BP from task levels at
45 min averaged 26.6mmHg in the higher SES/small WHR group,
22.15mmHg in the lower SES/small WHR group, but only 16.22mmHg
in the lower SES/large WHR group (Table 3). Impaired post-stress re-
covery has previously been shown to predict clinical hypertension and
cardiovascular disease risk (Panaite et al., 2015). Our results suggest
that this pathway may link greater central adiposity with cardiovas-
cular risk among lower SES adults.
Resting values of all three inflammatory markers in this study (C-
reactive protein, IL-6 and fibrinogen) were inversely associated with
SES in a graded fashion (Table 2). This relationship has been recorded
in larger epidemiological studies as well (Nazmi and Victora, 2007;
Steptoe, 2012), and suggests that lower SES is characterised by low
grade systemic inflammation that may contribute to increased risk for
several physical and mental health outcomes, particularly at older ages
(Franceschi et al., 2018). The lower SES participants with greater
central adiposity had particularly raised levels of resting C-reactive
protein and plasma fibrinogen compared with other groups, together
with sustained elevations in fibrinogen throughout the mental stress
protocol. Inflammatory processes play a key role in linking cardiovas-
cular disease with fat distribution (Ferrucci and Fabbri, 2018). Central
or abdominal fat stores are a potent source of adipokines while also
contributing to high circulating levels of very-low-density lipoprotein,
reduced high-density lipoprotein concentrations, and excess fatty acid
flux (Piche et al., 2018). Central adiposity predicts cardiovascular risk
independently of total body fat or BMI (Abraham et al., 2015; Liu et al.,
2010). Plasma IL-6 did not conform to this pattern. The SES gradients in
IL-6 and fibrinogen present at baseline were sustained throughout the
study, but the increases in IL-6 concentration following stress occurred
in parallel across the three SES groups. So although the highest levels
were apparent in the lower SES group at 75min post-stress, there was
no differential reactivity. In a previous study, we observed that IL-6
concentration continued to increase among lower SES participants be-
tween 75 and 120min following stress, whereas it stabilised in the
higher SES group (Brydon et al., 2004). It is possible therefore that
differences might have emerged if blood sampling had continued. Fi-
brinogen responses were more transient, but again occurred in parallel
across SES groups, replicating results in an earlier smaller study
(Steptoe et al., 2003a). There was a flatter rise in IL-6 among people
with greater WHR, but no interaction with SES.
The cortisol responses to this protocol were small, although in-
dividual differences still predicted variations in cardiovascular risk and
telomere attrition longitudinally (Hamer et al., 2012; Steptoe et al.,
2017). Salivary cortisol was elevated throughout the mental stress
testing session in lower compared with intermediate and higher SES
groups, and lower SES individuals also showed greater cortisol output
over the day (Figs. 2 and 4). There were SES differences in the changes
in cortisol across the stress session, but it is difficult to interpret these as
differences in rate of post-stress recovery (Le-Scherban et al., 2018).
Studies relating SES with diurnal cortisol profiles have generated con-
flicting results, although several have documented flatter slopes of
cortisol recline over the day (Desantis et al., 2015; Hajat et al., 2010).
Others have focused on the cortisol awakening response (Kunz-Ebrecht
et al., 2004). We did not find any differences in the cortisol awakening
response or in slope of decline over the day, but instead a difference in
overall output that was independent of age, sex, smoking, and BMI.
The absence of differences in cortisol responses between WHR
groups was unexpected, since several previous studies have shown as-
sociations (Bjorntorp, 2001; Incollingo Rodriguez et al., 2015). It is
notable that the majority of studies in this field have assessed associa-
tions of cortisol with central adiposity without adjusting for BMI as was
done in these analyses (Champaneri et al., 2013; Incollingo Rodriguez
et al., 2015). As can be seen in Appendix A, Table 2, analyses that did
not take general adiposity into account revealed more extensive dif-
ferences related to WHR than did the adjusted analyses. But failure to
adjust for BMI makes it more difficult to identify specific associations
with central adiposity. Another explanation for the lack of striking as-
sociations with central obesity may relate to the study sample. Although
the differences in central adiposity between the small and large WHR
groups were marked, the body weights of this healthy cohort of older
men and women were generally relatively moderate. It is possible that
stress-related biological and psychosocial processes implicated in cen-
tral adiposity will only be manifest among more overweight or obese
individuals.
The interaction between lower SES and greater central adiposity in
the proportion of respondents with CMV infection has not been docu-
mented before (Table 4). A socioeconomic gradient in CMV infection
has also been noted in population studies (Dowd et al., 2009), and
positive serostatus predicts all-cause mortality, CHD and hypertension
risk (Du et al., 2018; Hui et al., 2016; Simanek et al., 2011). Molecular
biological studies suggest that the infection is concentrated in en-
dothelial cells leading to endothelial injury, subsequently affecting
smooth muscle cell proliferation and promoting atherogenesis (Du
et al., 2018). The present study cannot determine whether lower SES
individuals with greater abdominal adiposity are at higher risk of in-
fection, or whether CMV infection among lower SES groups drives the
development of central adiposity. Nonetheless, the interaction suggests
that infectious pathways to cardiovascular disease risk may be parti-
cularly important among less affluent people with central adiposity.
This study was carried out with a well characterised population that
was selectively sampled to encompass a broad range of SES. Existing
cardiovascular disease was excluded, so that associations are not sec-
ondary to differences in health status. The size of the sample was large
by comparison with many investigations of stress-related inflammatory
responses. However, the selection process resulted in a sample of in-
dividuals with relatively normal body weights, and only 14% had a
BMI≥ 30. The impact of central adiposity may be greater among
people who have more general obesity. The study was carried out with
men and women of white European origin, and results may not gen-
eralise to other groups. SES was defined by occupational status, and
other criteria such as educational attainment or income might generate
different results. The cross-sectional design makes it impossible to draw
causal conclusions about the directionality of effects. It is likely that
there is a bidirectional relationship between central adiposity and stress
biology, with greater abdominal fat contributing to the expression of
adipokines and other markers, while stress stimulates more rapid ac-
cumulation of fat stores. Findings may also be limited by having only
one session of mental stress testing and sampling cortisol over a single
day. Nonetheless, the findings extend the evidence relating lower SES to
stress-related biological risk factors for cardiovascular disease, while
indicating that central adiposity may augment SES differences in in-
flammation and impaired recovery in cardiovascular function following
acute mental stress.
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